For Year 2025-26, Aristo Bio-Tech and Lifescience reports the following shareholding: Total Promoters at 73.42%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 26.58%. This breakdown provides a quick snapshot of ownership distribution for Aristo Bio-Tech and Lifescience in 2025-26.